Iterum Therapeutics plc Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Iterum Therapeutics plc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • Iterum Therapeutics plc Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $378K, a 76.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $378K -$1.22M -76.3% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $464K -$1.22M -72.4% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $549K -$1.22M -69% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 $630K -$1.23M -66.1% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $1.6M -$618K -27.9% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $1.68M -$1.98M -54% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $1.77M -$1.97M -52.7% Dec 31, 2022 10-K 2024-03-28
Q3 2022 $1.86M -$2.04M -52.3% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $2.21M -$1.87M -45.8% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $3.66M -$1.59M -30.3% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $3.74M -$1.52M -28.9% Dec 31, 2021 10-K 2023-03-16
Q3 2021 $3.89M -$2.84M -42.2% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $4.08M -$2.81M -40.8% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $5.25M -$1.77M -25.2% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $5.26M -$1.88M -26.4% Dec 31, 2020 10-K 2022-03-28
Q3 2020 $6.74M -$529K -7.28% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $6.89M -$494K -6.69% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $7.02M -$485K -6.46% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $7.14M Dec 31, 2019 10-K 2021-03-12
Q3 2019 $7.27M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $7.39M Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $7.5M Mar 31, 2019 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.